301 BINNEY STREET, CAMBRIDGE, MA
Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Scholar Rock Files Prospectus Supplement for ATM Program with Jefferies
Shareholder Vote Results from Scholar Rock Annual Meeting on June 4, 2026
Investor Presentation
Annual Report to Security Holders
Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
Earnings Release
Amended material disclosure
Q2
Q1
FY 2025
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Free Writing Prospectus
Correspondence
Submission Upload